Intratracheal delivery of aerosolized monoclonal antibodies with specificity for Yersinia pestis LcrV and F1 antigens protected mice in a model of pneumonic plague. These data support the utility of inhaled antibodies as a fast-acting postexposure treatment for plague.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459704 | PMC |
http://dx.doi.org/10.1128/IAI.74.5.3068-3070.2006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!